Pulmonary Cell News Volume 4.02 | Jan 22 2015

    0
    18
    Pulmonary Cell News 4.02 January 22, 2014

    Pulmonary Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  PULCN on Twitter

     
    TOP STORY
    Pyruvate Carboxylase Is Critical for Non-Small-Cell Lung Cancer Proliferation
    Investigators infused patients with early-stage non-small-cell lung cancer with uniformly 13C-labeled glucose before tissue resection and determined that the cancerous tissues in these patients had enhanced pyruvate carboxylase (PC) activity. PC knockdown induced multinucleation, decreased cell proliferation and colony formation in human non-small-cell lung cancer cells, and reduced tumor growth in a mouse xenograft model. [J Clin Invest] Full Article
    [Free Webinar] A Guide To Successful Flow Cytometry Analysis of ALDHbr Cells - Watch Now

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Increased IL-33 Expression in Chronic Obstructive Pulmonary Disease
    Researchers investigated the expression of interleukin-33 (IL-33) in chronic obstructive pulmonary disease (COPD) and to aimed determine whether IL-33 participates in the initiation and progression of COPD. [Am J Physiol Lung Cell Mol Physiol] Abstract

    Temporal-Spatial Variations of the Physicochemical Characteristics of Air Pollution Particulate Matter (PM2.5-0.3) and Toxicological Effects in Human Bronchial Epithelial Cells (BEAS-2B)
    Researchers studied some physicochemical characteristics and toxicological endpoints of PM2.5-0.3 samples produced during two different seasons in three different surroundings were studied, thereby expecting to differentiate their respective adverse effects in BEAS-2B cells. [Environ Res] Abstract

    Role of p53-Fibrinolytic System Cross-Talk in the Regulation of Quartz-Induced Lung Injury
    Scientists explored whether p53-mediated changes in the urokinase-type plasminogen activator (uPA) system contributes to silica-induced lung injury. Treatment of wild-type mice with caveolin-1 scaffolding domain peptide inhibits PAI-1, restores uPA expression and prevents alveolar epithelial cell apoptosis by suppressing p53, which is otherwise induced in mice exposed to silica. [Toxicol Appl Pharmacol] Abstract

    Conditional Overexpression of TGFβ1 Promotes Pulmonary Inflammation, Apoptosis and Mortality via TGFβR2 in the Developing Mouse Lung
    Researchers revealed that increased transforming growth factor beta 1 (TGFβ1) expression in newborn mice lungs leads to increased mortality, macrophage and immature monocyte infiltration, apoptotic cell death specifically in type II alveolar epithelial cells, impaired alveolarization, and dysregulated angiogenic molecular markers. [Respir Res] Abstract | Full Article

    Desialylation of Airway Epithelial Cells during Influenza Virus Infection Enhances Pneumococcal Adhesion via Galectin Binding
    Researchers examined the possibility that galectins expressed in the airway epithelial cells might play a significant role in viral or pneumococcal adhesion to airway epithelial cells. [Mol Immunol] Abstract

    LUNG CANCER

    Targeting LunX Inhibits Non-Small-Cell Lung Cancer Growth and Metastasis
    Researchers report the identification of a novel candidate therapeutic target, LunX, as a molecule overexpressed in primary non-small-cell lung cancer and lymph node metastases that is associated with reduced postoperative survival. Functional studies demonstrated that LunX overexpression promoted lung cancer cell migration and proliferation by interactions with the chaperone protein 14-3-3. [Cancer Res] Abstract

    Role of Nicotinic Acetylcholine Receptors in Cell Proliferation and Tumor Invasion in Broncho-Pulmonary Carcinomas
    Scientists examined the localization of nicotinic acetylcholine receptors (nAChRs) in human lung tumors and, by using primary cultures of tumor cells derived from these tumors, determining the nAChR roles in cell proliferation and tumor invasion. [Lung Cancer] Abstract

    β-Elemene Inhibited Expression of DNA Methyltransferase 1 through Activation of ERK1/2 and AMPKα Signaling Pathways in Human Lung Cancer Cells: The Role of Sp1
    Researchers show that β-elemene inhibits human non-small cell lung carcinoma cell growth, and increased phosphorylation of ERK1/2, Akt and AMPKα. [J Cell Mol Med] Abstract

    Hsp90 Inhibitor NVP-AUY922 Enhances the Radiation Sensitivity of Lung Cancer Cell Lines with Acquired Resistance to EGFR-Tyrosine Kinase Inhibitors
    Scientists evaluated the radiosensitizing effect of the novel Hsp90 inhibitor, NVP-AUY922, on non-small cell lung cancer cell lines harboring epidermal growth factor receptor (EGFR) activating mutations and showing acquired resistance to EGFR-tyrosine kinase inhibitors via any of several mechanisms. [Oncol Rep] Abstract

    Request a Sample: ReproTeSRâ„¢

     
    REVIEWS
    Efficacy and Adverse Effects of Drugs Used to Treat Adult Cystic Fibrosis
    The authors bring together the various treatments being used to prolong and enhance the quality of life of cystic fibrosis patients. New concepts have been formed and some positive results in this direction have already led to the approval of cystic fibrosis transmembrane conductance regulator potentiator drug. [Expert Opin Drug Saf] Abstract

    Visit our reviews page to see a complete list of reviews in the pulmonary cell research field.

     
    INDUSTRY NEWS
    Ventana Seeks FDA Premarket Approval for ALK IHC Companion Diagnostic to Benefit Lung Cancer Patients
    Ventana Medical Systems, Inc. announced its FDA submission for premarket approval of the VENTANA ALK companion diagnostic assay. [Ventana Medical Systems, Inc.] Press Release

    Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring
    Trovagene, Inc. announced it will expand the clinical collaboration with Genomac Research Institute. Trovagene Precision Cancer MonitoringSM technology will be used in two prospective clinical studies for the early detection of emerging oncogene mutations indicative of resistance to targeted therapies used to treat colorectal and lung cancer. [Trovagene, Inc.] Press Release

    From our sponsor: Free human hematopoietic progenitors wallchart. Request your copy.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Cellular Therapy 2015 – 8th International Symposium on the Clinical Use of Cellular Products
    March 19-20, 2015
    Erlangen, Germany

    NEW 2nd International Congress on Stem Cell and Cellular Therapies (ICSCCT)
    October 15-18, 2015
    Antalya, Turkey

    Visit our events page to see a complete list of events in the pulmonary cell community.

     
    JOB OPPORTUNITIES
    NEW Director (California Institute for Regenerative Medicine)

    Postdoctoral Fellow – Lung Cancer (MD Anderson Cancer Center)

    Postdoctoral Fellow – Cystic Fibrosis Research (University of Tennessee Health Science Center)

    Postdoctoral Research Fellow – Post-Transcriptional Gene Regulation Governing Cancer Cell Behavior (Fred Hutchinson Cancer Research Center)

    Postdoctoral Fellow – Wnt Signaling in Development and Disease (Van Andel Research Institute)

    Staff Scientist – Lung Cancer (University of Pennsylvania)

    Postdoctoral Fellow – Cytokine-Induced Lung Inflammation (Cleveland Clinic Lerner Research Institute)

    Postdoctoral Positions – Lung and Dermal Uptake Modeling (Karolinska Institutet)

    Postdoctoral Position – Lung Cancer, Lung Regeneration and Lung Development (University of California – San Francisco)

    PhD Students – Heart and Lung Research (Max Planck Institute for Heart and Lung Research)

    Research Technologist – Media Development (STEMCELL Technologies Inc.)

    Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

    Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

    Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

    Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)


    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Pulmonary Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Pulmonary Cell News: Archives | Events | Contact Us